CN102199673A - Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system - Google Patents
Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system Download PDFInfo
- Publication number
- CN102199673A CN102199673A CN2010106054967A CN201010605496A CN102199673A CN 102199673 A CN102199673 A CN 102199673A CN 2010106054967 A CN2010106054967 A CN 2010106054967A CN 201010605496 A CN201010605496 A CN 201010605496A CN 102199673 A CN102199673 A CN 102199673A
- Authority
- CN
- China
- Prior art keywords
- japanese encephalitis
- quantitative pcr
- virus
- encephalitis
- encephalitis virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 29
- 238000003753 real-time PCR Methods 0.000 title claims abstract description 26
- 206010014599 encephalitis Diseases 0.000 title description 29
- 241000701076 Macacine alphaherpesvirus 1 Species 0.000 title 2
- 238000003752 polymerase chain reaction Methods 0.000 title 2
- 239000000523 sample Substances 0.000 claims abstract description 42
- 238000000034 method Methods 0.000 claims abstract description 31
- 241000710842 Japanese encephalitis virus Species 0.000 claims abstract description 16
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 230000003321 amplification Effects 0.000 claims description 22
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 22
- 238000013461 design Methods 0.000 claims description 14
- 239000013612 plasmid Substances 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 claims description 6
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 5
- 108020000999 Viral RNA Proteins 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000007405 data analysis Methods 0.000 claims description 4
- 238000003786 synthesis reaction Methods 0.000 claims description 4
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- BZTDTCNHAFUJOG-UHFFFAOYSA-N 6-carboxyfluorescein Chemical compound C12=CC=C(O)C=C2OC2=CC(O)=CC=C2C11OC(=O)C2=CC=C(C(=O)O)C=C21 BZTDTCNHAFUJOG-UHFFFAOYSA-N 0.000 claims description 2
- MGIODCZGPVDROX-UHFFFAOYSA-N Cy5-bifunctional dye Chemical compound O=C1CCC(=O)N1OC(=O)CCCCCN1C2=CC=C(S(O)(=O)=O)C=C2C(C)(C)C1=CC=CC=CC(C(C1=CC(=CC=C11)S([O-])(=O)=O)(C)C)=[N+]1CCCCCC(=O)ON1C(=O)CCC1=O MGIODCZGPVDROX-UHFFFAOYSA-N 0.000 claims description 2
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 claims description 2
- 206010014596 Encephalitis Japanese B Diseases 0.000 claims 3
- 201000005807 Japanese encephalitis Diseases 0.000 claims 3
- 238000012938 design process Methods 0.000 claims 1
- 238000012795 verification Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 241000710772 Yellow fever virus Species 0.000 abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 3
- 229940051021 yellow-fever virus Drugs 0.000 abstract description 3
- 241000725619 Dengue virus Species 0.000 abstract description 2
- 239000007983 Tris buffer Substances 0.000 abstract description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 abstract description 2
- 230000037029 cross reaction Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 241000700605 Viruses Species 0.000 description 22
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 238000000137 annealing Methods 0.000 description 7
- 108020004414 DNA Proteins 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 3
- 206010052369 Encephalitis lethargica Diseases 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000002498 viral encephalitis Diseases 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 238000012882 sequential analysis Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公布了一种乙型脑炎病毒荧光定量PCR检测新方法及乙型脑炎病毒检测PCR体系，由引物和探针、Premix Ex Taq反应液、灭菌Tris水组成，该引物和探针检测特异性好，灵敏度高，非常适用于乙脑病毒，与登革热病毒、黄热病毒无交叉反应。
The invention discloses a new method for detecting Japanese encephalitis virus fluorescent quantitative PCR and a Japanese encephalitis virus detection PCR system, which are composed of primers and probes, Premix Ex Taq reaction solution, and sterilized Tris water. The primers and probes It has good detection specificity and high sensitivity, and is very suitable for Japanese encephalitis virus, and has no cross-reaction with dengue virus and yellow fever virus.
Description
Technical field
The invention belongs to field of biological detection, be specifically related to step on fast qualitative and the quantitative detecting method and the encephalitis b virus detection PCR system of encephalitis b virus, a pair of Auele Specific Primer and probe are provided.
Background technology
(epidemic encephalitis B JE) is called for short encephalitis to epidemic encephalitis type B, claims japanese encephalitis virus through the mosquito media transmission again by encephalitis b virus, causes the acute viral transmissible disease based on central nervous system damage.Distributed more widely, comprise the torrid zone, subtropics, temperate zone and area, middle temperate zone, some countries of South East Asia are especially many, and global reported cases are counted every year more than 16000, dead 5000 examples.The diagnostic method that uses for encephalitis has the detection of ELISA serology, hemagglutination-inhibition test (HI), RT-PCR detection of nucleic acids etc. at present.But the method for quantitative fluorescent PCR detection of nucleic acids was not also used, it can yet be regarded as a kind of more directly perceived, be fit to the examination criteria of early diagnosis accurately and rapidly.
Summary of the invention
The object of the present invention is to provide a kind of encephalitis b virus fluorescence quantitative PCR detection novel method and encephalitis b virus to detect the PCR system, this method can fast qualitative and detection by quantitative encephalitis b virus, comprises that a pair of specificity is higher, highly sensitive, the primer of good reproducibility and probe.
For achieving the above object, encephalitis b virus fluorescence quantitative PCR detection novel method of the present invention, wherein the primer probe of design employing is:
| Name | Sequence | Position | Tm℃ | Modification |
| FP | GTTTATCTGTGTGAACTTCTTGGC | 5-28 | 57.9 | ? |
| RP | TTTAGTCATGGTTATCTTCCGTTC | 81-104 | 57.7 | ? |
| Rrobe | AGTATCGTTGAGAAGAATCGAGAGATTAGTGC | 31-62 | 67.8 | CY3/BHQ-2 |
Further, described encephalitis b virus fluorescence quantitative PCR detection novel method is specially:
1) design primer probe;
2) select fluorescein according to instrument;
3) synthetic primer and probe;
4) preparation positive plasmid standard substance;
5) operation PCR;
6) data analysis;
7) extract viral RNA and carry out the system checking.
Further, described step 2) the selective fluorescent emission group of fluorescein has 6-FAM, TET, HEX, JOE, CY3, CY5, TAMRA, Texas Red in, and the fluorescent quenching group has BHQ-1, BHQ-2, Lowa Black
TMRQ, Lowa Black
TMFQ, Dabcyl.
Further, take the gene synthesis mode to make positive plasmid CBG229-1 as positive in the described step 4): to carry out gene synthetic with prolonging 5～50bp before and after the high conserved region territory bp5-bp104 that filters out in the design of primers process respectively, be cloned into then in the pMD19-T carrier, be described positive plasmid sample, numbering CBG229-1.
Further, the quantitative fluorescent PCR reaction is applicable to all quantitative fluorescent PCR reaction instrument in the described step 5).
Further, described quantitative fluorescent PCR reaction instrument comprises SmartCyclerII, ABI real-time PCR system, BioRad PCR in real time detection system, Stratagene quantitative polumerase chain reaction instrument.
Further, best amplification condition is in the described step 5):
A kind of encephalitis b virus detects the PCR system, and this system comprises that primer or other can combine the primer that is equal to of also amplification with encephalitis B full length sequence specificity, and its similar homology can not surpass 90%, and primer sequence is as follows:
A kind of encephalitis b virus detects the PCR system, this system comprise primer and can with encephalitis B full length sequence specific probe, probe sequence is as follows:
Can combine the probe that is equal to of also amplification with encephalitis B full length sequence specificity, the fraction of coverage of its site areas can not surpass 50%, and its homology can not surpass 70%.
The present invention designs a pair of new primer probe, sets up a kind of fluorescence quantitative PCR method in conjunction with utilization SmartCyclerII and detects encephalitis b virus.Pick out the conservative sequence of encephalitis b virus genome camber by the mode of sequence alignment, the a pair of primer of design and a Taqman probe on this sequence, set up the real-time fluorescence quantitative PCR reaction system, and be optimized, detect the sensitivity and the specificity of this method.
Description of drawings
Fig. 1 is that the two dimension of amplification curve shows figure;
Fig. 2 is 1e
3, 1e
2, 1e
1, 1e
0The amplification curve diagram of four gradient templates of copies/ μ l; X-axis is represented the amplification cycles number, and Y-axis is represented fluorescence signal intensity;
Fig. 3 is 1e
0The graphic representation of 6 parallel amplifications of copies/ μ l template;
Fig. 4 is that repeatability detects synoptic diagram;
Fig. 5 is a canonical plotting.
Embodiment
The principle of work of encephalitis b virus fluorescence quantitative PCR detection novel method of the present invention promptly is to utilize the variation qualitative analysis of fluorescent signal, detect the variation of each cyclic amplification product amount in the pcr amplification reaction in real time, starting template is carried out quantitative analysis by the relation of Ct value and typical curve.The invention still further relates to all the elements that above-mentioned detection architecture comprises.
This method may further comprise the steps:
1) design primer probe;
2) select fluorescein according to instrument;
3) synthetic primer and probe;
4) preparation positive plasmid standard substance;
5) operation PCR;
6) data analysis;
7) extract viral RNA and carry out the system checking.
1, the design of primer probe
According to intending research gene title encephalitis B (epidemic encephalitis B, JE), in genebank, find corresponding complete genome sequence (www.ncbi.nlm.nih.gov), utilization DNASTAR software carries out homology analysis and blast sequential analysis, sift out high conservative zone bp5-bp104 as target sequence, adopt primer-design software Primer Premier 5 to carry out the design of primer probe, sequence sees Table 1.
The primer and the probe of table 1 fluorescence quantitative PCR detection encephalitis b virus
| Name | Sequence | Strand | Position | Tm℃ | Modification |
| FP | GTTTATCTGTGTGAACTTCTTGGC | forward | 5-28 | 57.9 | ? |
| RP | TTTAGTCATGGTTATCTTCCGTTC | reverse | 81-104 | 57.7 | ? |
2, the selection of fluorescein
Use the SmartCyclerII of instrument as U.S. Cepheid company, the fluorescent emission group adopts CY3, and the fluorescent quenching group adopts BHQ-2.
3, the synthetic of primer and probe gives precious biotechnology (Dalian) company limited to finish.
4, the present invention takes the gene synthesis mode to make positive plasmid as positive.To carry out gene synthetic with prolonging 30～50bp before and after the high conserved region territory bp5-bp104 that filters out in the design of primers process respectively, is cloned into then in the pMD19-T carrier, is our positive plasmid sample, numbering CBG229-1.
5, the preparation of standard substance
Synthetic by authorized company and extract positive plasmid sample stoste, recording concentration by the ultramicron ultraviolet spectrophotometer is 301ng/ μ l, calculates according to the copy number calculation formula " copy number concentration (copies/ μ l)=DNA concentration (ng/ μ l) * 6.02 * 1023 (copies/mol)/324 * 2 * (carrier base number+goal gene base number) " of single stranded DNA and learns that the DNA copy number concentration of plasmid stoste is about 1 * 10
11Copies/ μ l.Use EASY Dilution (a kind of liquid that is specifically designed to standard substance dilution use, precious biotech firm produces by Dalian) to carry out gradient dilution and finally obtain 1 * 10
0～1 * 10
10The plasmid standard of copies/ μ l.
6, primer and probe dissolved dilution are to desired concn and keep in Dark Place.
Primer generally is diluted to 10 μ m/L, and probe dilution is to 5 μ m/L, and-20 ℃ of refrigerators seal and keep in Dark Place.Dilution institute water is sterilization Tris water (Ph7.0～8.0).
7, Real-Time pcr amplification
The amplification kit of selecting for use is Premix Ex Taq, available from precious biotechnology (Dalian) company limited.Reaction system component and volume see Table 2.
Table 2
Amplification condition is as follows
8, data analysis
9, extract viral RNA, carry out reverse transcription, gained cDNA uses the aqua sterilisa gradient dilution, replaces positive and carries out detection validation.
The selection of threshold value
In the process of the various parameter optimizations of quantitative fluorescent PCR, the Ct value is the reference factor of most critical.The method of calculating the Ct value has in conjunction with two kinds of method of intersection and quafric curve Peak Intensity Method.We will react the threshold line that presents in the amplification curve diagram and drag up and down, para-curve in conjunction with the amplification rate velocity of variation is observed, when the pairing Ct value of the intersection point of threshold line and amplification curve is passed through the peak value of quafric curve just, the threshold value of this moment is optimal threshold, and the Ct value also is Ct value the most accurately.With reference to figure 1, determine that the body series optimal threshold is 11.
The optimization of primer concentration and probe concentration
1. it is standby to lower concentration at first to dilute the primer probe, and primer is diluted to 10 μ m/L, and probe is to 5 μ m/L;
Respectively to each system add 0.5 μ L, 1 μ L, 2 μ L have diluted upstream and downstream primer (10 μ m/L), 0.5 μ L, 1 μ L, 2 μ L Taqman probes (5 μ m/L) move PCR simultaneously, other components of system are pressed table 2 preparation; The preferred optimum response concentration combination of relative method, determine that finally the best proportioning of primer concentration and probe concentration in the 25 μ l encephalitis b virus quantitative fluorescent PCR reaction systems is: primer 400nmol/L, probe 200nmol/L promptly adds respectively and has diluted good each 1 μ L of primer probe.
The selection of annealing temperature
Under the perfect condition, annealing temperature is enough low, effectively anneals with aim sequence to guarantee primer, wants enough high simultaneously, to reduce non-specific binding.Following carrying out when annealing temperature is set: be lower than that design estimates during primer Tm5 ℃ as initial annealing temperature, with 2 ℃ be increment, progressively improve annealing temperature.5 groups of temperature of initial setting: 52 ℃, 54 ℃, 56 ℃, 58 ℃, 60 ℃.All the purpose fragment be can detect under five groups of annealing temperatures, this primer and probe better performances proved, adaptable wider range.But the minimum temperature of the strongest while Ct of fluorescent signal value is 54 ℃, determines that finally optimum annealing temperature is 54 ℃.
The mensuration of sensitivity
Detect gradient template, Fig. 2 according to reaction system of having optimized and response procedures. be 1e
3, 1e
2, 1e
1, 1e
0The detected result figure of four gradient templates, Fig. 3. be 1e
0Copies/ μ l template is made the curve of 6 parallel amplifications, so because the lower quantity that increases parallel detection of template concentrations, five feminine genders of a positive appear in the result, so lowest detectable limit can only reach tens level, 1e
1The dilution DNA of copies/ μ l.
Repeatability detects
Fig. 4. be 1e
6～1e
2The dna profiling quantitative fluorescent PCR of five concentration gradients of copies/ μ l, each gradient have all been done 2 to 3 parallel laboratory tests, and the amplification curve that each gradient template produced among the figure has all produced and has been consistent Ct value, and repeatability is very good.
The specificity check
Detect dengue virus, the yellow fever virus that belongs to yellow hot section with encephalitis b virus with the system of being set up, the result is all negative.Show that this designed primer probe specificity is very high.
The foundation of typical curve
The quality of system can reflect that the e value levels off to 1 more by amplification efficiency e, amplification efficiency is described more near 100%, and reaction system is good more; E＜1 illustrates that the system amplification efficiency is lower, and system needs to optimize; Inhibition is contained in the explanation system in e＞1, needs to reduce even get rid of the interference of inhibition.The amplification efficiency optimum range of generally acknowledging in this field is between 0.8-1.2.Adopt 1e
6～1e
2Copies/ μ l template increases, and the gained typical curve is Fig. 5., the amplification function
Y=-0.31X+13.278, amplification efficiency e=10-k-1=1.04=104%.(k＝-0.31)
Purpose of the present invention is exactly a pair of new primer probe of design, sets up a kind of fluorescence quantitative PCR method in conjunction with utilization SmartCyclerII and detects encephalitis b virus.Pick out the conservative sequence of encephalitis b virus genome camber by the mode of sequence alignment, the a pair of primer of design and a Taqman probe on this sequence, set up the real-time fluorescence quantitative PCR reaction system, and be optimized, detect the sensitivity and the specificity of this method.Detection method of the present invention is highly suitable for encephalitis b virus, with dengue fever virus, yellow fever virus no cross reaction.
Claims (9)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106054967A CN102199673A (en) | 2010-12-24 | 2010-12-24 | Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010106054967A CN102199673A (en) | 2010-12-24 | 2010-12-24 | Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102199673A true CN102199673A (en) | 2011-09-28 |
Family
ID=44660657
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010106054967A Pending CN102199673A (en) | 2010-12-24 | 2010-12-24 | Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102199673A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108103242A (en) * | 2017-12-19 | 2018-06-01 | 浙江丰安生物制药有限公司 | The oral freeze-dried powder intermediate encephalitis B virus nucleic acid detection method of spleen aminopeptide |
| CN112280903A (en) * | 2020-11-17 | 2021-01-29 | 深圳国际旅行卫生保健中心(深圳海关口岸门诊部) | Primer probe combination, encephalitis virus detection kit and application thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1829796A (en) * | 2002-10-09 | 2006-09-06 | Cid株式会社 | The full-length genome PNA of a new Japanese encephalitis virus, its infectious JEV cDNA and its application |
-
2010
- 2010-12-24 CN CN2010106054967A patent/CN102199673A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1829796A (en) * | 2002-10-09 | 2006-09-06 | Cid株式会社 | The full-length genome PNA of a new Japanese encephalitis virus, its infectious JEV cDNA and its application |
Non-Patent Citations (2)
| Title |
|---|
| 刘卫滨等: "乙型脑炎病毒TaqMan PCR检测方法的建立及初步应用", 《中华微生物学和免疫学杂志》 * |
| 郑夔等: "实时荧光RT-PCR快速检测蚊体内乙型脑炎病毒及福建省基因I型乙型脑炎病毒的发现", 《中国卫生检验杂志》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108103242A (en) * | 2017-12-19 | 2018-06-01 | 浙江丰安生物制药有限公司 | The oral freeze-dried powder intermediate encephalitis B virus nucleic acid detection method of spleen aminopeptide |
| CN112280903A (en) * | 2020-11-17 | 2021-01-29 | 深圳国际旅行卫生保健中心(深圳海关口岸门诊部) | Primer probe combination, encephalitis virus detection kit and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102140529A (en) | New dengue virus fluorescence quantitative polymerase chain reaction detection method and dengue virus polymerase chain reaction detection system | |
| CN102140530B (en) | New chikungunya virus fluorescence quantitative polymerase chain reaction detection method and chikungunya virus polymerase chain reaction detection system | |
| CN101979666B (en) | Fluorescence quantitative polymerase chain reaction (PCR) kit for quickly detecting herpes simplex viruses 2 | |
| CN111074000A (en) | Triple fluorescence quantitative PCR detection material and kit for distinguishing ASFV wild strain and double-gene deletion strain | |
| CN102140543B (en) | Multiple real-time quantitative PCR primer, probe and detection method for identifying viral pathogens relevant to fever with eruption syndrome as infection diseases | |
| CN102140532A (en) | Novel Ebola virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and system | |
| CN102191338A (en) | Fluorescence quantitative polymerase chain reaction (PCR) new method for detecting multiple viruses of yellow fever, dengue fever and epidemicencephalitis B and multiple virus detection PCR system | |
| CN109182481B (en) | A method for high-throughput detection of multiple target genes | |
| CN105324492A (en) | Dual probes for DNA and RNA detection: anti-probe compositions | |
| CN105112564A (en) | Method and kit for detecting high-risk HPV (human papillomavirus) E6/E7 mRNA (messenger ribonucleic acid) by ligase | |
| CN102140533B (en) | Marburg and Ebola dual-virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and dual-virus detection PCR system | |
| CN105886664B (en) | For human papilloma virus E6/E7 genetic test kit and detection method | |
| CN102140531A (en) | Novel Marburg virus fluorescent quantitative PCR (Polymerase Chain Reaction) detection method and Marburg virus PCR detection system | |
| CN105132584A (en) | Kit for genotyping VZV, production method of kit and application of kit | |
| CN102277446B (en) | A new method for the detection of yellow fever virus by fluorescent quantitative PCR and a PCR system for the detection of yellow fever virus | |
| CN102363818A (en) | Treble real-time fluorescence quantitative polymerase chain reaction (PCR) method for simultaneously detecting epstein-barr virus (EBV), polyma virus (BKV) and cytomegalovirus (CMV) of people and kit | |
| CN102140528B (en) | New fluorescence quantitative polymerase chain reaction (PCR) detection method for rift valley fever virus and rift valley fever virus detection PCR system | |
| CN102199673A (en) | Novel fluorescence quantitative PCR (Polymerase Chain Reaction) detection method of encephalitis B virus and encephalitis B virus detection PCR system | |
| CN106319079B (en) | Method for detecting 22q11.2 copy number loss | |
| CN104561383A (en) | Influenza A virus and B virus joint detection primer, probe, kit and application | |
| CN107287352A (en) | The probe primer group and its method of duck enteritis virus and duck hepatitis virus quick detection | |
| CN103205502B (en) | Fluorescence quantification PCR (Polymerase Chain Reaction) primer, probe and kit for detecting dog leptospira nucleic acid | |
| CN102605088B (en) | Method for rapidly detecting copy number variation of alpha-globin gene cluster | |
| CN110747261A (en) | A specific primer, detection method and application of a tetracycline antibiotic resistance gene tetX | |
| CN106755567B (en) | Real-time fluorescence quantitative PCR (polymerase chain reaction) detection primer, probe, detection kit and detection method for simian SRV (sequence-related syndrome Virus) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20110928 |